Robert Wallis, MD

Robert Wallis, MD, is the chief scientific officer at the Aurum Institute and adjunct professor in the department of medicine at Vanderbilt University Medical Center.

Articles by Robert Wallis, MD

Robert Wallis, MD I Credit: Vanderbilt University

Sutezolid Shows Promise as Safer Oxazolidinone in Novel 4-Month TB Regimen

ByRobert Wallis, MD

June 8th 2026

At ATS 2026, Robert Wallis, MD, discussed PanTB-HM findings on FEV1 recovery and NAC antimicrobial interactions.

Novel 4-Month Pan-TB Regimens Show Promise for Lung Function Recovery

ByRobert Wallis, MD

May 18th 2026

At ATS 2026, Robert Wallis, MD, shared preliminary phase 2c data showing a novel 4-month pan-TB regimen containing sutezolid and N-acetylcysteine improved lung function recovery.

Robert Wallis, MD

Articles by Robert Wallis, MD

Sutezolid Shows Promise as Safer Oxazolidinone in Novel 4-Month TB Regimen

Novel 4-Month Pan-TB Regimens Show Promise for Lung Function Recovery

Latest Updated Articles

Trending on HCPLive

The HCPFive: Top News for Healthcare Providers from the Week of 06/07

GLP-1 Initiation Associated With Increase in Hypotensive Events in Patients With Hypertension

MiniMed 780G Associated With Reduced HbA1c, Increased Time in Range

How Environmental Triggers Impact Skin Disease, With Hannah Rodriguez, MPAS, PA-C

Weight Loss Improves Cardiometabolic Biomarkers in Digital Metabolic Reset Program